Abstract

PurposeArterio-ureteral fistula (AUF) is an uncommon diagnosis, but potentially lethal. Although the number of reports has increased over the past two decades, the true incidence and contemporary urologists’ experience and approach in clinical practice remains unknown. This research is conducted to provide insight in the incidence of AUF in The Netherlands, and the applied diagnostic tests and therapeutic approaches in modern practice.MethodsA nationwide cross-sectional questionnaire analysis was performed by sending a survey to all registered Dutch urologists. Data collection included information on experience with patients with AUF; and their medical history, diagnostics, treatment, and follow-up, and were captured in a standardized template by two independent reviewers. Descriptive statistics were used.ResultsResponse rate was 62% and 56 AUFs in 53 patients were reported between 2003 and 2018. The estimated incidence of AUF in The Netherlands in this time period is 3.5 AUFs per year. Hematuria was observed in all patients; 9% intermittent microhematuria, and 91% presenting with, or building up to massive hematuria. For the final diagnosis, angiography was the most efficient modality, confirming diagnosis in 58%. Treatment comprised predominantly endovascular intervention.ConclusionThe diagnosis AUF should be considered in patients with persistent intermittent or massive hematuria.

Highlights

  • Arterio-ureteral fistula (AUF) is a rare but potentially lethal complication, where a direct connection between artery or vascular graft and ureter exists

  • First clinical presentation is often intermittent hematuria, without any additional symptoms, which frequently ceases without any treatment [1, 2]

  • AUF may present with massive hematuria, especially during endoscopic ureteral instrumentation and/or stent replacement

Read more

Summary

Introduction

Arterio-ureteral fistula (AUF) is a rare but potentially lethal complication, where a direct connection between artery or vascular graft and ureter exists. First clinical presentation is often intermittent hematuria, without any additional symptoms, which frequently ceases without any treatment [1, 2]. AUF may present with massive hematuria, especially during endoscopic ureteral instrumentation and/or stent replacement. Lock and Kyara Kamphorst contributed to this paper

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.